血清甲胎蛋白和凝血酶原活动度水平对慢加急性肝衰竭患者预后的预测价值研究

doi:10.3969/j.issn.1672-5069.2017.02.027

Abstract

Zhao Ping， Zhai Yufeng，Zhang Huaihong.. Application of serum alpha fetoprotein and prothrombin time activity in predicting prognosis of patients with acute-on-chronic liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 230-231.

References

[1] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志，2013，16（3）：210-216.
[2] Liaw YF， Leung N， Piratvisuth T， et al. Asian pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int，2008，2:263-283.
[3] Liu Q， Liu Z， Wang T， et al. Characteristics of acute and subacute liver failure in China:nomination， classification and interval. Gastroenterol Hepatol， 2007， 22（12）:2101-2106.
[4] 苗静，吴素琼，郭丽颖，等. 甲胎蛋白和胆碱酯酶在乙型肝炎病毒相关慢加急性肝衰竭患者中应用价值的研究. 中华危重病急救医学， 2016， 28（3）:257-261.
[5] 邹正升，陈菊梅，辛绍杰，等. 565 例重型病毒性肝炎的临床特点分析. 中华肝脏病杂志， 2001， 9（4）:247-248.
[6] 叶一农，高志良. 乙型肝炎肝衰竭发生机制中的三重打击. 传染病信息， 2009 （5）:276-279.
[7] Lucena S，Salazar AM ，Gil A，et al. The action of Lonomin V （Lonomia achelous） on fibronectin functional properties.Thromb Res，2008，121（5）:653-661．
[8] Jimbo R，Sawase T，Shibata Y，et al． Enhanced osseointegration by the chemotactic activity of plasma fibronectin for cellular fibronectin positive cells. Biomaterials，2007，28（24）:3469-3477．
[9] 陈灏珠.内科学. 北京：人民卫生出版社，1997:411-419.
[10] 汤朝晖，全志伟，刘颖斌，等. AFP、GPC3、ZHX2 及 ZBTB20基因在小鼠肝脏再生过程中的表达及其意义. 中华肝脏外科手术学杂志电子版，2013，2（1）:39-44.
[11] 徐少卿，郭建彪，李红艳，等. 血清甲胎蛋白与慢加急性肝衰竭预后的关系. 临床消化病杂志， 2014，13（1）:46-47.
[12] 刘春文，许飞，罗一钧，等. 血清前白蛋白与甲胎蛋白早期动态变化在肝衰竭预后判断中的价值. 环球中医药， 2013，6（S2）:16-17.
[13] 阮承兰，张骏飞，宋海燕，等. 肝衰竭预后影响因素的Logistic回归分析.中华疾病控制杂志，2014，18（6）:537-540.
[14] 陈应强，庄海，李向永，等. 甲胎蛋白对慢性HBV感染后重型肝炎预后的预测价值. 广东医学杂志，2015，36（5）: 721-722.
[15] 李友炳，张军，陈靖，等. 肝功能衰竭患者血清磷和甲胎蛋白检测的临床意义. 中华传染病杂志， 2014， 32（8）: 470-473.
[16] Sass DA， Shakil AO. Fulminant hepatic failure. Liver Transplant， 2005， 11（6）:594-605.
[17] 吴云忠，赵凤林，张春泽，等. 慢性重型乙型肝炎转归相关因素及病毒治疗研究. 中华实验和临床病毒学杂志， 2007， 21（6）: 120-122.
[18] Yuen MF， Sablon E， Hui CK， et al. Prognostic factors in severe exacerbation of chronic hepatitis B. Clin Infect Dis， 2003， 36 （8）:979-984.

Application of serum alpha fetoprotein and prothrombin time activity in predicting prognosis of patients with acute-on-chronic liver failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[2]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[3]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[4]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[5]	Wang Yuan, Dang Panyu, Wang Wei. Application of plasma exchange and continuous plasma dialysis filtration in the treatment of patients with acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 541-544.
[6]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[7]	Zhong Song, Liu Yuyuan, Liu Shuren. G2D expression of peripheral blood natural killer cells in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 341-344.
[8]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[9]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[10]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Chen Haiou, Liu Shi.. Implication of serum IL-10 and GP73 levels in patients with HBV-related acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 73-76.
[13]	Ma Deyuan, Ma Yuanfeng, Zhang Dianlong, et al.. Prognostic efficacy of serum keratin 18 in patients with hepatitis B virus-related acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 77-80.
[14]	Yan Huanjie, Zhang Shuqin, Zhao Wenjing.. Therapeutic efficacy of autologous bone marrow stem cell transplantation for treatment of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 81-84.
[15]	Zhang Jing, Yin Fang, Luo Guanhong, et al.. Effect of plasma exchange and sequential double plasma molecular adsorbent therapy on short survival in patients with hepatitis B virus-induced acute on chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 85-88.